Keywords: gilead, sees, positive, results, ph, i/ii, trials

Gilead sees positive results in Ph I/II trials of HIV drug

Article | 16 January 2006

Print This

California, USA-based Gilead Sciences says that it has completed a Phase I/II study of JTK-303, an oral HIV integrase ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in